Adagio Medical Holdings, INC DEF 14A proxy statements
Proxy statements, covering the matters put to shareholders at the annual meeting — board elections, auditor ratification and executive pay.
NASDAQ
Adagio Medical Holdings, Inc. has issued its proxy statement for the 2026 Annual Meeting of Stockholders to be held virtually on June 16, 2026.
NASDAQ
Adagio Medical Holdings, Inc. announced the appointment of Sean Salmon, former Medtronic EVP, as a Class II independent director to its Board, Audit, and Compensation Committees.
NASDAQ
Adagio Medical Holdings, Inc. announces its 2025 Annual Meeting of Stockholders to elect directors and ratify its independent accounting firm, while addressing recent capital raises and governance changes.